All In Biotech

Drug Trial Radar · NCT03418974

Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia

Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia: A Network Register-based Follow-up Study

Last checked: Nov 19, 2026Latest source record: Feb 1, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

10,000

Actual

Start

Nov 1, 2017

Primary completion

Dec 31, 2021

Study completion Dec 31, 2021

Sponsor

Lead sponsor
Fudan UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Peking University People's Hospital; Jiangsu Wanbang Medicine Marketing Co., Ltd.
First posted
Feb 1, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to verify the clinical efficacy and safety of different statins in dyslipidemia patients, and explore the effects on glycometabolic in patients with impaired glucose regulation.

Conditions

  • Dyslipidemias

Interventions

  • PitavastatinDrug

    Capsule/Tablet, oral, follow the doctor's advice Participants will receive pitavastatin treatment for 3 or 12 weeks.

  • AtorvastatinDrug

    Capsule/Tablet, oral, follow the doctor's advice Participants will receive atorvastatin treatment for 3 or 12 weeks.

  • RosuvastatinDrug

    Capsule/Tablet, oral, follow the doctor's advice Participants will receive rosuvastatin treatment for 3 or 12 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. LDL-C target achieving rateTime frame: 3 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Heart Center of Peking University People's Hospital

    Beijing, Beijing Municipality, China

  • School of Public Health, Fudan University

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.